secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2024-01-22T23:59:59+00:00
Accession:  0001437749-24-001852
Event type: other_material
Sentiment:  neutral
Materiality: 0.80
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Perspective Therapeutics closes $89.8M combined public offering and Lantheus private placement
--------------------------------------------------------------------------------

- Gross proceeds: $69.0M from public offering + $20.8M from private placement = $89.8M total.
- Public offering: 156.4M shares at $0.37/sh and pre-funded warrants for 30.1M shares at $0.369/sh.
- Private placement to Lantheus: 56.3M shares at $0.37/sh for $20.8M gross.
- Proceeds to fund R&D, clinical trials, manufacturing, and potential acquisitions.
- Underwriters' option for 24.3M additional shares was exercised in full.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774924001852/0001437749-24-001852-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774924001852/isr20240121_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-001852

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer